FUNCTION OF RECEPTOR-BOUND UROKINASE

被引:29
作者
KIRCHHEIMER, JC
BINDER, BR
机构
关键词
D O I
10.1055/s-2007-1002616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:246 / 250
页数:5
相关论文
共 64 条
[1]  
ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644
[2]   HORMONAL-REGULATION OF EXTRACELLULAR PLASMINOGEN ACTIVATORS AND MR - 54000 PLASMINOGEN-ACTIVATOR INHIBITOR IN HUMAN NEOPLASTIC CELL-LINES, STUDIED WITH MONOCLONAL-ANTIBODIES [J].
ANDREASEN, PA ;
CHRISTENSEN, TH ;
HUANG, JY ;
NIELSEN, LS ;
WILSON, EL ;
DANO, K .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1986, 45 (2-3) :137-147
[3]   IMMUNOLOGICAL IDENTITY OF UROKINASE AND OVARIAN CARCINOMA PLASMINOGEN ACTIVATOR RELEASED IN TISSUE-CULTURE [J].
ASTEDT, B ;
HOLMBERG, L .
NATURE, 1976, 261 (5561) :595-597
[4]  
ASTEDT B, 1985, THROMB HAEMOSTASIS, V53, P122
[5]  
BOYD D, 1988, BIOCHIM BIOPHYS ACTA, V947, P96
[6]  
BUSSO N, 1986, J BIOL CHEM, V261, P9309
[7]  
BUSSO N, 1987, CANCER RES, V47, P364
[8]   ACCESSIBILITY OF RECEPTOR-BOUND UROKINASE TO TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CUBELLIS, MV ;
ANDREASEN, P ;
RAGNO, P ;
MAYER, M ;
DANO, K ;
BLASI, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :4828-4832
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]  
DELROSSO M, 1987, BRIT J HAEMATOL, V66, P289